Rockwell Medical

Rockwell Medical, Inc. is a fully integrated biopharmaceutical company targeting the treatment of End-Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD) through innovative products and services aimed at treating iron deficiency, secondary hyperparathyroidism, and hemodialysis. Rockwell Medical is also a renowned producer and leader, providing high-quality hemodialysis concentrates/dialysis to dialysis providers and distributors both in the United States and internationally. As one of the two major suppliers in the U.S., Rockwell Medical's products are used to remove toxins from the blood of dialysis patients and replace essential nutrients to sustain human life. Rockwell Medical has three production and sales facilities in the U.S., with an operational infrastructure that serves as a ready-made sales and distribution channel, enabling seamless integration for its drug products, Calcitriol and SFP, upon FDA market approval. Rockwell Medical's exclusive renal drug therapies support disease management programs aimed at improving patient quality of life and care for dialysis patients, while focusing on delivering safe and effective treatments, reducing medication management costs, and enhancing patient convenience. Rockwell Medical is also developing a drug treatment method, including expanding indications beyond hemodialysis.